1 엄유현, "Whole Brain Voxel-Wise Analysis of Cerebral Retention of Beta-Amyloid in Cognitively Normal Older Adults Using 18F-Florbetaben" 대한신경정신의학회 14 (14): 883-886, 2017
2 Jack CR Jr, "Tracking pathophysiological processes in Alzheimer’s disease : an updated hypothetical model of dynamic biomarkers" 12 : 207-216, 2013
3 Veronese M, "Quantification of C-11 PIB PET for imaging myelin in the human brain : a test—retest reproducibility study in high-resolution research tomography" 35 : 1771-1782, 2015
4 Landau SM, "Optimizing longitudinal amyloid-β PET measurement : the challenges of intensity normalization" 59 : 1581-1582, 2018
5 Presotto L, "Low-dose CT for the spatial normalization of PET images : a validation procedure for amyloid-PET semi-quantification" 20 : 153-160, 2018
6 Barthel H, "Influence of ethnic group, age, gender, and tracer mass dose on florbetaben β-amyloid brain PET results in elderly normal controls" 6 : S436-, 2010
7 Tuszynski T, "Evaluation of software tools for automated identification of neuroanatomical structures in quantitative β-amyloid PET imaging to diagnose Alzheimer’s disease" 43 : 1077-1087, 2016
8 Ampil ER, "Ethnic variability in dementia : results from Singapore" 19 : 184-185, 2005
9 Barthel H, "Cerebral amyloid-β PET with florbetaben(18F)in patients with Alzheimer’s disease and healthy controls : a multicentre phase 2 diagnostic study" 10 : 424-435, 2011
10 Sabri O, "Beta-amyloid imaging with florbetaben" 3 : 13-26, 2015
1 엄유현, "Whole Brain Voxel-Wise Analysis of Cerebral Retention of Beta-Amyloid in Cognitively Normal Older Adults Using 18F-Florbetaben" 대한신경정신의학회 14 (14): 883-886, 2017
2 Jack CR Jr, "Tracking pathophysiological processes in Alzheimer’s disease : an updated hypothetical model of dynamic biomarkers" 12 : 207-216, 2013
3 Veronese M, "Quantification of C-11 PIB PET for imaging myelin in the human brain : a test—retest reproducibility study in high-resolution research tomography" 35 : 1771-1782, 2015
4 Landau SM, "Optimizing longitudinal amyloid-β PET measurement : the challenges of intensity normalization" 59 : 1581-1582, 2018
5 Presotto L, "Low-dose CT for the spatial normalization of PET images : a validation procedure for amyloid-PET semi-quantification" 20 : 153-160, 2018
6 Barthel H, "Influence of ethnic group, age, gender, and tracer mass dose on florbetaben β-amyloid brain PET results in elderly normal controls" 6 : S436-, 2010
7 Tuszynski T, "Evaluation of software tools for automated identification of neuroanatomical structures in quantitative β-amyloid PET imaging to diagnose Alzheimer’s disease" 43 : 1077-1087, 2016
8 Ampil ER, "Ethnic variability in dementia : results from Singapore" 19 : 184-185, 2005
9 Barthel H, "Cerebral amyloid-β PET with florbetaben(18F)in patients with Alzheimer’s disease and healthy controls : a multicentre phase 2 diagnostic study" 10 : 424-435, 2011
10 Sabri O, "Beta-amyloid imaging with florbetaben" 3 : 13-26, 2015
11 Becker JA, "Amyloid-β associated cortical thinning in clinically normal elderly" 69 : 1032-1042, 2011
12 Alzheimer’s Association, "2018 Alzheimer’s disease facts and figures" 14 : 367-429, 2018